Copertina

Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies

Since it acquired pandemic status, SARS-CoV-2 has been causing all kinds of damage all over the world. More than 6.3 million people have died, and many cases of sequelae are in survivors. Currently, the only products available to most of the world's population to fight the pandemic are vaccines...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Alberto Jorge Oliveira Lopes (Autore), Gustavo Pereira Calado (Autore), Yuri Nascimento Fróes (Autore), Sandra Alves de Araújo (Autore), Lucas Martins França (Autore), Antonio Marcus de Andrade Paes (Autore), Sebastião Vieira de Morais (Autore), Cláudia Quintino da Rocha (Autore), Cleydlenne Costa Vasconcelos (Autore)
Natura:	Libro
Pubblicazione:	MDPI AG, 2022-08-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

An in Silico Approach to Find the Molecular Targets and Potential Candidates for SARS-CoV-2
di: Amir Zarrinhaghighi, et al.
Pubblicazione: (2020)

Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
di: Patricia Rijo, et al.
Pubblicazione: (2022)

In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease
di: Ekaterina Serikova, et al.
Pubblicazione: (2022)

Anti-Inflammatory and Antioxidant Activity of Pollen Extract Collected by <i>Scaptotrigona affinis postica</i>: in silico, in vitro, and in vivo Studies
di: Alberto Jorge Oliveira Lopes, et al.
Pubblicazione: (2020)

In silico study of the toxicity of hyperforin and its metabolites
di: Ivelin Iliev, et al.
Pubblicazione: (2023)

SARS-CoV-2 vaccine candidates in rapid development
di: Lifeng Li, et al.
Pubblicazione: (2021)

In silico, in vitro screening of plant extracts for anti-SARS-CoV-2 activity and evaluation of their acute and sub-acute toxicity
di: Damle Latha, et al.
Pubblicazione: (2022)

Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies
di: Queency N. Okechukwu, et al.
Pubblicazione: (2024)

In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus
di: Natália Ferreira de Sousa, et al.
Pubblicazione: (2024)

A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV
di: Sitesh C. Bachar, et al.
Pubblicazione: (2021)

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
di: Ahmed A. Al-Karmalawy, et al.
Pubblicazione: (2023)

Candidate genes for infertility: an in-silico study based on cytogenetic analysis
di: Jatinder Singh Sahota, et al.
Pubblicazione: (2022)

Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents
di: Bussayarat Maikhunthod, et al.
Pubblicazione: (2024)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
di: Elena Campione, et al.
Pubblicazione: (2021)

Tamarind (Tamarindus indica L.) Seed a Candidate Protein Source with Potential for Combating SARS-CoV-2 Infection in Obesity
di: Ana H. de A. Morais, et al.
Pubblicazione: (2021)

African and Asian Medicinal Plants as a Repository for Prospective Antiviral Metabolites Against HIV-1 and SARS CoV-2: A Mini Review
di: Godwin Anywar, et al.
Pubblicazione: (2021)

Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant
di: Marcus Estrada, et al.
Pubblicazione: (2024)

Antioxidant activity of plant secondary metabolites
di: Marčetić Mirjana, et al.
Pubblicazione: (2023)

Comparative In-Silico Molecular Docking of Silymarin for SARS-CoV-2 Receptor
di: Michael Antony Samy Amutha Gnana Arasi, et al.
Pubblicazione: (2022)

Plant Tissue Culture and Secondary Metabolites Production
Pubblicazione: (2023)

Antinociceptive Activity of Borreria verticillata: In vivo and In silico Studies
di: Rosa H. M. Silva, et al.
Pubblicazione: (2017)

Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India
di: Peter Solo, et al.
Pubblicazione: (2021)

Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
di: Keneth Iceland Kasozi, et al.
Pubblicazione: (2020)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
di: Khan Sharun, et al.
Pubblicazione: (2020)

Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicity
di: Sharareh Mohammad Hasani, et al.
Pubblicazione: (2024)

Inhibitory Effects of Salinispora-derived Metabolites Against Multidrug Resistance: An In-silico Study
di: Morteza Ghandadi
Pubblicazione: (2020)

Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment
di: Niteen A. Vaidya, et al.
Pubblicazione: (2020)

Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies
di: Wenyuan Shang, et al.
Pubblicazione: (2024)

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
di: Sathish Kumar Chidambaram, et al.
Pubblicazione: (2020)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
di: Baby Krishnaprasad, et al.
Pubblicazione: (2020)

In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein
di: Gabriel Rodrigues Coutinho Pereira, et al.
Pubblicazione: (2023)

In-vitro Cytotoxicity and In-silico Insights of the Multi-target Anticancer Candidates from Haplophyllum tuberculatum
di: Mosab Yahya Al-Nour, et al.
Pubblicazione: (2021)

Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry
di: Erum Zafar, et al.
Pubblicazione: (2022)

Antimicrobial Metabolites of Caucasian Medicinal Plants as Alternatives to Antibiotics
di: Marta Fik-Jaskółka, et al.
Pubblicazione: (2024)

Plant metabolite diosmin as the therapeutic agent in human diseases
di: Saad Mustafa, et al.
Pubblicazione: (2022)

Trigonelline Alkaloid, a Valuable Medicinal Metabolite Plant
di: A Mehrafarin, et al.
Pubblicazione: (2012)

Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation
di: Rajeev K. Singla, et al.
Pubblicazione: (2021)

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy
di: Cijo George Vazhappilly, et al.
Pubblicazione: (2023)

Current approaches toward production of secondary plant metabolites
di: Md. Sarfaraj Hussain, et al.
Pubblicazione: (2012)

Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in <i>Mycobacterium tuberculosis</i> from Plant-Derived Metabolites: An In Silico Study
di: Kratika Singh, et al.
Pubblicazione: (2022)